Barrett Evans - 15 May 2025 Form 3 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)

Reporting relationship: ex CEO, Director, 10%+ Owner
Issuer ticker: PTIX
Reported as of: 15 May 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 24 Oct 2025, 13:40:30 UTC
Prior SEC filing: 11 Aug 2021
Next SEC filing: 24 Oct 2025
Source filing: View source filing
Reporting owner signature: Barrett Evans

Key filing fact

Barrett Evans filed Form 3 for Protagenic Therapeutics, Inc.\new (PTIX) on 24 Oct 2025.

Key facts

This page summarizes Barrett Evans's Form 3 filing for Protagenic Therapeutics, Inc.\new (PTIX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 24 Oct 2025, 13:40.

Change

Previous filing in this sequence was filed on 11 Aug 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (3)

CIK 0001277242 Primary reporting owner

EVANS BARRETT

Relationship: ex CEO, Director, 10%+ Owner
Address: 701 ANACAPA STREET, SUITE C, SANTA BARBARA
Signature: Barrett Evans
Signature date: 23 Oct 2025

CIK 0001905629

EMC2 Capital LLC

Relationship: ex CEO, Director, 10%+ Owner
Address: 701 ANACAPA STREET, SUITE C, SANTA BARBARA
Signature: Barrett Evans
Signature date: 23 Oct 2025

CIK 0001877347

Mammoth Crest Capital LLC

Relationship: ex CEO, Director, 10%+ Owner
Address: 701 ANACAPA STREET, SUITE C, SANTA BARBARA
Signature: Barrett Evans
Signature date: 23 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PTIX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 16,233
Date: 15 May 2025
Ownership: These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
Footnotes: F1

PTIX holding

Preferred Stock Series C

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 787
Date: 15 May 2025
Ownership: These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
Footnotes: F1

PTIX holding

Preferred Stock Series C-1

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 131,034
Date: 15 May 2025
Ownership: These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
Footnotes: F1

PTIX holding

Preferred Stock Series D

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,000
Date: 15 May 2025
Ownership: Direct
Footnotes: F1

PTIX holding

Preferred Stock Series D

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,498
Date: 15 May 2025
Ownership: These shares are owned by EMC2 Capital LLC. Mr. Evans is a managing member.
Footnotes: F1

PTIX holding

Preferred Stock Series D

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,000
Date: 15 May 2025
Ownership: These shares are owned by Mammoth Crest Capital LLC. Mr. Evans is a managing member.
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Mr. Evans was the CEO and is a Director of PTIX

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .